The Skeptical
Investing Blog

A higher-for-longer US rates outlook could weigh on the HSI through tighter Hong Kong financial conditions and weaker capital flows, creating an attractive leveraged downside opportunity via HSI put warrants.

Ultragreen.AI is down c40% over the past month as its "monopoly" status has come under threat with new entrants gaining FDA approvals in the US for ICG. We think the share price reaction is overdone as both volumes and ASP erosion could be more manageable than expected. Read on for more.

Using a VIX Oct/Nov 19 put calendar to position for elevated election-related volatility into November and compression post-election